The ARK Genomic Revolution Multi-Sector ETF (NYSEArca: ARKG) fund may focus on biotechnological advances, but it’s been delivering freak of nature-like returns as of late. With ARKG up over 40% YTD despite the pandemic sell-off in March, it’s been a stellar performer and one that exchange-traded...